Cargando…
Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage
INTRODUCTION: Chemotherapy-related endothelial damage contributes to the early development of cardiovascular morbidity in testicular cancer patients. We aimed to identify relevant mechanisms of and search for candidate biomarkers for this endothelial damage. METHODS: Human micro-vascular endothelial...
Autores principales: | Altena, Renske, Fehrmann, Rudolf S. N., Boer, Hink, de Vries, Elisabeth G. E., Meijer, Coby, Gietema, Jourik A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295859/ https://www.ncbi.nlm.nih.gov/pubmed/25590623 http://dx.doi.org/10.1371/journal.pone.0115372 |
Ejemplares similares
-
Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy
por: Steggink, Lars C., et al.
Publicado: (2020) -
Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis
por: van der Schoot, Gabriela G. F., et al.
Publicado: (2023) -
GDF15 and Growth Control
por: Emmerson, Paul J., et al.
Publicado: (2018) -
The Role of GDF15 as a Myomitokine
por: Johann, Kornelia, et al.
Publicado: (2021) -
Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy
por: Fejzo, M, et al.
Publicado: (2023)